Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis

Cited by (664)

Items 501–600 of 664

1. Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is It All About ME1?
   Vivek Subbiah, Boyi Gan · 2022 · Clinical Cancer Research
2. Applications of CRISPR/Cas technology against drug-resistant lung cancers: an update
   Mayank Chaudhary, Pooja Sharma, Tapan Kumar Mukherjee · 2022 · Molecular Biology Reports
3. Low glutaminase and glycolysis correlate with a high transdifferentiation efficiency in mouse cortex
   Yuan Li, Tingting Yang, Yingying Cheng, Jinfei Hou, Zhaoming Liu, Yu Zhao, Shiyu Chen, Zhaohui Steve Qin, Chenchen Wang, Weining Song et al. · 2023 · Cell Proliferation
4. A Transcriptomic Approach Outperforms Mutational Analysis to Identify KEAP1/NFE2L2 Pathway Activation in Patients With NSCLC
   Sara Hijazo‐Pechero, Cristina Muñoz‐Pinedo, Ernest Nadal · 2023 · Journal of Thoracic Oncology
5. Cancer Therapies Targeting Cellular Metabolism
   Benjamin L. Morris, Alejandro Gutiérrez · 2024 · Cold Spring Harbor Perspectives in Medicine
6. New insights into reductive stress responses and its clinical relation in cancer
   Suman Kumar Ray, Sukhes Mukherjee · 2025 · Tissue and Cell
7. Overview of glutamine metabolism in stromal components of the tumor microenvironment and potential anti-tumor therapies
   Zizhuo Li, Jiapeng Deng, Hai Wang, Tao Liu, Yaou Zhou, Pei Ouyang, Xuan Liang, Xian Zhang, Songtao Qi, Yaomin Li · 2025 · Genes & Diseases
8. Applications and Complementarity of Organ‐Chips and Animal Models in Lung Cancer Driver Gene Research
   Lu‐Kai Wang, Tsai‐Jung Wu, Fu‐Ming Tsai · 2025 · Cell Biology International
9. Systematic and precise interventions for KRAS-mutant cancers
   JingHui Liang, JunXi Wu, Yuan Zhang, Hongyu Wang, YiYang Zheng, Qing He · 2026 · Experimental Hematology and Oncology
10. Development of PROTACs for targeted degradation of oncogenic TRK fusions
    Saurav Kumar, Jiewei Jiang, Mia S. Donald-Paladino, Joy Chen, Andrea Gutierrez, Alexander Joel Federation, Frank Szulzewsky, Eric C. Holland, Fleur M. Ferguson, Behnam Nabet · 2026 · RSC Chemical Biology
11. LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1 -Mutant Lung Cancer
    Ray Pillai, Ali Rashidfarrokhi, Yuan Hao, Warren Wu, Mariana Camargo Silva Mancini, Burcu Karadal-Ferrena, Sofia G. Dimitriadoy, Michael Cross, Anna H. Yeaton, Shih Ming Huang et al. · 2026 · Cancer Discovery
12. Pan-cancer proteogenomic interrogation of the ubiquitin-proteasome system
    Tania J González-Robles, Maha Khan, Paul Sastourne-Haletou, Marisa Triola, Hua Zhou, Yuki Kito, Sharon Kaisari, David Fenyö, Gergely Róna, Yadira M. Soto‐Feliciano et al. · 2026 · Cell Death and Differentiation
13. Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines
    Konstantin H. Dragnev, Ronald A. Lubet, Mark Steven Miller, Shizuko Sei, Jennifer T. Fox, Ming You · 2023 · Cancer Prevention Research
14. Cancer Therapy Potential Unveiled: FDA‐Approved Drugs Targeting Glutaminase for Breast Cancer Treatment
    Raziyeh Mirshekaran, Khadijeh Ahmadi, Behzad Shahbazi, Gholamreza Farshidfar, Ebrahim Eftekhar, Soudabeh Kavousipour · 2024 · ChemistrySelect
15. CYP4F11, an NRF2 Target Gene, Promotes Hepatocellular Carcinoma Cell Growth
    Jinjing Chen, Carlee A. Trindl, Hong Ye, Dichun Huang, Aikseng Ooi, Joe G. N. Garcia, Eli Chapman, Donna D. Zhang · 2025 · Molecular Carcinogenesis
16. NRF2-mediated persistent adaptation of oesophageal adenocarcinoma cells to HER2 inhibition
    Wei Zhang, Jiaqing Lang, Sorayut Chattrakarn, Chun Wai Wong, Shi-Yang Li, Karmern Kan, Hongcai Liu, Wenchao Gu, Jingwei Zhang, Jukka K. Westermarck et al. · 2025 · Oncogene
17. Mapping cancer gene dynamics through state-specific interactions
    Adrian Maqueda Real, Laia Ollé-Monràs, Solip Park · 2025 · Cell Reports
18. Revealing the subtyping of non‐small cell lung cancer based on genomic evolutionary patterns by multi‐region sequencing
    Gaoming Liao, Xin Liang, Yanyan Ping, Yong Zhang, Jianlong Liao, Yihan Wang, Xiaobo Hou, Zedong Jiang, Xiaoqiu Dong, Chaohan Xu et al. · 2020 · Cancer Medicine
19. KEAP1/NRF2 Mutations in Stem Cells Define an Aggressive Subset of Head and Neck Cancer Patients Who Have a Poor Prognosis, Lung Metastasis, and Therapeutic Failure
    Syed Shahidul Islam, Bedri Karakas, Abdelilah Aboussekhra, Abu Shadat Mohammod Noman · 2023 · Cancers
20. KBTBD2 promotes proliferation and migration of gastric cancer via activating EGFR signaling pathway
    Jishuang Ding, Wei Gao, Haiying Yang, Lei Duan, Dong Sun, Luguang Liu, Xianlin Qu, Hang Yu, Botao Xu, Siwei Zhao et al. · 2024 · Pathology - Research and Practice
21. Drugging the undruggable: Advances in targeting KRAS signaling in solid tumors
    Prajna Tripathi, Rajni Kumari, Rajiv Pathak · 2024 · International review of cytology
22. CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research
    Xian Gong, Jianting Du, Ren‐Wang Peng, Chun Chen, Yang Zhang · 2024 · Cancers
23. KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis
    Song Liu, Futao Liu, Xingguo Hou, Qian Zhang, Yanan Ren, Hua Zhu, Zhi Yang, Xiaoxia Xu · 2024 · Molecular Pharmaceutics
24. Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer
    Piyada Sitthideatphaiboon, Chonnipa Nantavithya, Poonchavist Chantranuwat, Chanida Vinayanuwattikun, Virote Sriuranpong · 2024 · Scientific Reports
25. The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma
    Ruigang Dou, Rongfeng Liu, Peng Su, Xiaohui Yu, Yanzhao Xu · 2024 · Open Medicine
26. Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation
    Chuan Yu, Ofir Stefanson, Yueli Liu, Zhu A. Wang · 2018 · Journal of Visualized Experiments
27. Deciphering cellular heterogeneity of pancreatic tumours
    Xiphias Ge Zhu, Kıvanç Birsoy · 2019 · Nature Cell Biology
28. Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation
    Chuan Yu, Ofir Stefanson, Yueli Liu, Zhu A. Wang · 2018 · Journal of Visualized Experiments
29. NRF1 or NRF2: Emerging Role of Redox Homeostasis on PERK/NRF/Autophagy Mediated Antioxidant in Tumor and Patient Dependent Chemo Sensitivity
    Sanaz Dastghaib, Sayed Mohammad Shafiee, Fatemeh Ramezani, Niloufar Ashtari, Farhad Tabasi, Javad Saffari‐Chaleshtori, Omid Vakili, Morvarid Siri, Somayeh Igder, Mojdeh Zamani et al. · 2024 · Preprints.org
30. TRPA1 channel mediates oxidative stress defense in cancer
    Nobuaki Takahashi · 2023 · Folia Pharmacologica Japonica
31. Comprehensive multi-omics analysis of tandem duplicator phenotypes in non-small cell lung cancer
    Jie Li, Xinyan Pan, Yanting Bi, Jian Huang, Jun Peng, ChunLing Bai, Jianhong Hou, Chen Yang · 2025 · Frontiers in Medicine
32. DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC
    Zeal P. Kamdar, Ethan Neumann, Kathryn Howe, Donald Long, Waqar Arif, Daniel H. Shu, Aditya A Mohan, Emma Kartalia, Jeric P. Hernandez, Solomon Levin et al. · 2025 · Journal of Hepatology
33. Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer
    Linsha Zhu, Xiangbo Jia, Lei Xu, Li Chen, Xiangning Fu, Hua Yan, Bo Ai, Shu Peng · 2025 · iScience
34. Long noncoding RNA PCAT7 confers radioresistance of esophageal squamous cell carcinoma by promoting GCLM-mediated anti-ferroptosis
    Hao Yu, Xixi Zhao, Xiaobo Shi, Junxiang Zhang, Xiaozhi Zhang, Yue Ke, Wei Guo, Xiangyun Ma, Xiaoxiao Liu, Yuchen Wang et al. · 2026 · Journal of Translational Medicine
35. RETRACTED: Immunometabolism in lung cancer – The link between metabolism and immune response
    Yasamin Eivazzadeh, Niloufar Orooji, Tamana Eskandari, Mahdieh Tarahomi, Fatemeh Tavassoli Razavi, Dariush Haghmorad · 2026 · iScience · Retracted
36. The oncogenic signalosome: SQSTM1/p62 as a master integrator of signaling, metabolism, and autophagy in cancer
    Choi Eun-ji, Sang-Min Jeon · 2026 · Toxicological Research
37. Development of a high-throughput screening platform for identification of functional BACH1 inhibitors reveals compounds with anti-invasive potential
    Kevin X. Ali, Donika Klenja-Skudrinja, Maureen Higgins, David Walker, Yumna Sharaf, Martin Dankis, Angana A. H. Patel, Dorota Raj, Jozefina J. Dzanan, Esben B. Svenningsen et al. · 2026 · Redox Biology
38. Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibition
    Melat T. Gebru, David Stokoe · 2026 · Frontiers in Cell and Developmental Biology
39. Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer
    Scott Best, Daniel S. Hippe, Eli Grunblatt, Jackson P. Fatherree, Pritha Chanana, Feinan Wu, Richard G. Ivey, Jacob J. Kennedy, David Sokolov, Ali Ibrahim et al. · 2026 · Nature Communications
40. A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma
    Chong Yau Fu, Chang Cheng, Yanping Zhang · 2023 · Heliyon
41. Emerging Role of Ferroptosis in Breast Cancer: Characteristics, Therapy, and Translational Implications for the Present and Future
    Suman Kumar Ray, Sukhes Mukherjee · 2023 · Current Molecular Medicine
42. Construction of a lung adenocarcinoma prognostic model based on KEAP1/NRF2/HO‑1 mutation‑mediated upregulated genes and bioinformatic analysis
    Wei Zhu, Zhang Ye, Lingyun Yang, Lu Chen, Chaobo Chen, Qifeng Shi, Zipeng Xu · 2025 · Oncology Letters
43. Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels
    Hironori Satoh, Yasuhito Arai, Eisaku Furukawa, Takashi Moriguchi, Natsuko Hama, Tomoko Urushidate, Yasushi Totoki, Mamoru Kato, Yuichiro Ohe, Masayuki P. Yamamoto et al. · 2022 · Carcinogenesis
44. CRISPR-Cas9 system “a mighty player in cancer therapy”
    Siddharth Manvati, Pawan Kumar Dhar · 2020 · Elsevier eBooks
45. A non-canonical function of LDHB promotes SLC7A11-mediated glutathione metabolism and protects against glutaminolysis-dependent ferroptosis in KRAS -driven lung cancer
    Liang Zhao, Haibin Deng, Jingyi Zhang, Nicola Zamboni, Gerrit Adriaan Geest, Haitang Yang, Yang Zhang, Yanyun Gao, Duo Xu, Haiqing Zhong et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
46. Aging promotes lung cancer metastasis through epigenetic ATF4 induction
    Angana A. H. Patel, Jozefina J. Dzanan, Kevin X. Ali, Ella Äng Eklund, Samantha Alvarez, Ilayda Altinönder, Dorota Raj, Ahmed Ezat El Zowalaty, Sama I. Sayin, Martin Dankis et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
47. Unraveling cysteine deficiency-associated rapid weight loss
    Alan Varghese, Ivan Gusarov, Begña Gamallo-Lana, Daria Dolgonos, Yatin Mankan, Ilya Shamovsky, Mydia Phan, Rebecca Jones, Maria Gomez-Jenkins, Eileen White et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
48. Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
    Christoph Arolt, Andreas Hans Scheel, Margaret Han Dugan, Robert Wild, Vanessa Richartz, Barbara Holz, Johannes Brägelmann, Svenja Wagener‐Ryczek, Sabine Merkelbach‐Bruse, Juergen Wolf et al. · 2024 · npj Precision Oncology
49. Unraveling disulfidptosis for prognostic modeling and personalized treatment strategies in lung adenocarcinoma
    Xiangyu Xu, Bingbing Zhang, Jin Zhang, Hongbiao Ma · 2024 · Future Science OA
50. Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Biomarker For “Cold” Tumor?
    Sita Andarini, Jamal Zaini · 2025 · Journal of Thoracic Oncology
51. The role of glutamine/Nrf2-enhanced PHGDH in Cadmium-induced lactate utilization
    Yuxin Pang, Shengnan Li, Qingxuan Zhang, Yuting Liu, Ying Kong, Jun Cao · 2025 · Free Radical Biology and Medicine
52. Amino acid restriction sensitizes lung cancer cells to ferroptosis via GCN2-dependent activation of the integrated stress response
    Viktor Garellick, Nadia Gul, Parvin Horrieh, Dyar Mustafa, Angana A.H. Patel, Martin Dankis, Samantha Alvarez, Johanna Berndtson, Saeed Mahdavi, Maria Schwarz et al. · 2025 · Redox Biology
53. Glycolytic/oxidative metabolic reprogramming in lung cancer: clinical implications for precision oncology
    Pedro Augusto Chikoski Albrecht, Bruna Klein Brun, Laura Saraiva, Fábio Klamt · 2026 · ONCOLOGIE
54. Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting
    Zhao Ruan, Xuedan Sun · 2026 · Hepatoma Research
55. KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers
    Man Yan, Kai Liu, Jiayi Xu, Yandi Liu, Liechen Ji, Shiwu Zhang · 2026 · Molecular Cancer
56. Machine learning-based integration of transcriptome and digital pathology for predicting chemoresistance in muscle-invasive bladder cancer
    Jinahn Jeong, Gowun Jeong, YongHwan Kim, Hyein Ju, Hyun Jun Im, Hyun Ji Kim, Ja-Min Park, Se Un Jeong, Seungun Lee, Min Gi Jang et al. · 2026 · Experimental & Molecular Medicine
57. On the Edge of Benefit and Harm: Reactive Oxygen Species in Cancer
    Anna B. Nikiforova · 2026 · International Journal of Molecular Sciences
58. Keap1ing an eye on Slc33A1
    Luke A. Gilbert · 2020 · Nature Cancer
59. Endogenous antioxidants in the prognosis and treatment of lung cancer
    Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Deben · 2021 · Elsevier eBooks
60. A PERSONALIZED ONCOLOGY MOBILE APPLICATION INTEGRATING CLINICAL AND GENOMIC FEATURES TO PREDICT THE RISK STRATIFICATION OF LUNG CANCER PATIENTS VIA MACHINE LEARNING
    Mehmet Cihan Sakman, Talip Zengin, Deniz Kurşun, Tuğba Önal-Süzek · 2022 · Mugla Journal of Science and Technology
61. An Unexpected Partnership: Histone Deacetylase 6 and Glutaminase Inhibition Provide an Opportunity to Overcome Resistance in KRAS and LKB1 Co-mutant Lung Tumors
    Brandon Nadres, Milica Momcilovic, David B. Shackelford, Aaron Elliott Lisberg · 2023 · Journal of Thoracic Oncology
62. Construction and Validation of an Oxidative Phosphorylation Signature in High‐Grade Glioma and Potential Inhibitors Screening
    Hanwen Lu, Wenpeng Zhao, Bingchang Zhang, Yuanyuan Xie, Jiawei He, Huiying Yang, Zhanxiang Wang · 2024 · Analytical Cellular Pathology
63. Computational modeling of metabolism in oncology
    Linda E. Fong, Meng Jin, Samir Kharbanda, Marc Creixell, Xiumin Wu, David Zhang, Juan Dubrot, Kathleen B. Yates, Robert T. Manguso, Benjamin Kaufmann-Malaga et al. · 2025 · Elsevier eBooks
64. Ferroptosis and its facet in Cancer therapy
    Shreya Shreshtha · 2021 · MOJ Biology and Medicine
65. Inhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC
    Rafael Rosell, Niki Karachaliou, Carles Codony, Masaoki Ito · 2018 · Translational Lung Cancer Research
66. NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition
    Douglas B. Fox, Ryan Lupo, Laura C. Noteware, Rachel Newcomb, Juan Liu, Jason W. Locasale, Matthew D. Hirschey, James V. Alvarez · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
67. Glutamine and CLL: ready for prime time?
    Silvia Deaglio · 2022 · Blood
68. DPP9 Overexpression in Clear Cell Renal Cell Carcinoma Causes Ferroptosis Suppression and Sorafenib Resistance Through the KEAP1–NRF2 Pathway
    Kun Sang Chang, yingji Chen, Xuanzhi Zhang, Wei Zhang, Bohan Zeng, Bo Dai, Fujiang Xu, Dingwei Ye, Chenji Wang · 2022 · Research Square
69. Metabolic Reprogramming by Histone Deacetylase Inhibition Selectively Targets NRF2-activated tumors
    Dimitris Karagiannis, Warren Wu, Albert Mao Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav S. Mangipudy, Xinjing Xu, Francisco J. Sánchez Rivera, Yadira M. Soto‐Feliciano et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
70. Controlled Chaos: Parsing Acquired Immunoresistance in Lung Cancer
    Brian S. Henick, Benjamin O. Herzberg, Carla P. Concepcion, Alison Marie Taylor · 2024 · Journal of Clinical Oncology
71. Tobacco smoke alters the trajectory of lung adenocarcinoma evolution via effects on somatic selection and epistasis
    Krishna Dasari, Jorge A. Alfaro-Murillo, Jeffrey P. Townsend · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
72. Tumor cell-intrinsic stress states drive sensitivity to CAR T cell-therapy in pancreatic cancer
    Julia Fröse, Evelyn Chen, Charles A. Whittaker, Paul Leclerc, Sean Doherty, Adam Langenbucher, Jasmine Shao, Riley D. Hellinger, Daniel R. Goulet, Tuomas Tammela et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
73. Study of the Role of NRF2 in the Progression and Metabolic Adaptation of Glioblastoma
    Maya M. Moubarak · 2024
74. Oncogenomics/Proteomics of Head and Neck Cancer
    Ruud H. Brakenhoff · 2018 · Springer eBooks
75. Minding the Ls and Qs
    Richard Possemato · 2019 · Nature Metabolism
76. Targeting glutamine metabolism enhances tumor specific immunity by inhibiting the generation of MDSCs and reprogramming tumor associated macrophages
    Min Hee Oh, Im‐Hong Sun, Liang Zhao, Robert D. Leone, Im-Meng Sun, Wei Xu, Samuel L. Collins, Ada J Tam, Richard L. Blosser, Chirag H. Patel et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
77. The kinase inhibitor AT9283 selectively kills colorectal cancer cells with hyperactive NRF2
    Laura Torrente, Gunjit Maan, Laura Casares, Angus W. Jackson, Tadashi Honda, Geoffrey Wells, Evgeny Kulesskiy, Jani Saarela, Albena T. Dinkova‐Kostova, Laureano de la Vega · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
78. The transcription factor NRF2 shapes the identity of radio-resistant tumor cells
    Gina Manda, Antonio Cuadrado, Instituto de Investigaciones Biomédicas “Alberto Sols” UAM-CSIC, Madrid, Spain · 2020 · Journal of Cell Identity
79. Tumor metabolic reprogramming in therapeutic resistance
    Peter M. Siegel, Josie Ursini‐Siegel · 2021 · Elsevier eBooks
80. Integrative omics analysis identifies subtypes with therapeutic implications in lung adenocarcinoma harboring KEAP1/NFE2L2
    Xiaodong Yang, Ming Li, Zhencong Chen, Liang Guo, Bo Jin, Yiwei Huang, Qun Wang, Liang Wu, Cheng Zhan · 2021 · Research Square
81. Tumor starvation by deprivation of glutamine and aspartate
    Robert Fried, Richard M. Carlton, Dennis A. Fried · 2021 · Elsevier eBooks
82. Promotion des métastases d’adénocarcinomes pulmonaires via la stabilisation du facteur de transcription BACH1
    Amel Ait Ali Said, Anthime Perrot, Corinne Dupuy · 2021 · médecine/sciences
83. Evidence-Based Medicine and Personalized Health Care
    Dirk T. Ubbink, Dink A. Legemate · 2021 · Springer eBooks
84. Mitochondrial Regulation Assessment by 13C-NMR Isotopomer Analysis
    Francisco X. Carvalho, Bárbara Guerra‐Carvalho, Ivana Jarak, Rui A. Carvalho · 2021 · Methods in molecular biology
85. マトリックスモデルとは何か?--治療プログラムの可能性と限界 (特集 DARS(Drug Addiction Recovery support)の理論と実践)
    俊彦 松本 · 2010
86. Genome Editing in Organoid to Improve Understanding of Human Disease
    Binhui Zhou, Yinming Liang · 2022 · Stem cell biology and regenerative medicine
87. Transposon Mutagenesis Reveals RBMS3 as a Promoter of Malignant Progression of BRAF V600E -Driven Lung Tumorigenesis
    Aria Vaishnavi, Joseph M. Juan, Michael T. Scherzer, J. Edward van Veen, Christopher M. Stehn, Christopher S. Hackett, Adam J. Dupuy, Steven A. Chmura, Louise van der Weyden, Justin Y. Newberg et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
88. Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
    Xiaodong Yang, Ming Li, Zhencong Chen, Fan Xiaobin, Liang Guo, Bo Ram Jin, Yiwei Huang, Qun Wang, Liang Wu, Cheng Zhan · 2022 · Journal of Cancer
89. Faculty Opinions recommendation of Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of bach1.
    Paul B. Fisher, Luni Emdad · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
90. Faculty Opinions recommendation of Glutamine deprivation alters the origin and function of cancer cell exosomes.
    Wei Guo, Diao Liu · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
91. Faculty Opinions recommendation of Commensal microbiota promote lung cancer development via γδ T cells.
    David L. Wiest, Alejandra Virginia Contreras · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
92. Emergencies/Resuscitation
    Ernst L.W. van Heurn · 2022 · Springer eBooks
93. Flavonoids Attentuate Cancer Metabolism by Modulating Redox State, lipid metabolism, and use of amino acids or ketone bodies
    Marek Samec, Alena Mazuráková, Vincent Lučanský, Lenka Koklesová, Renata Péčová, Martin Jozef Péč, Olga Golubnitschaja, Raghad Khalid AL-Ishaq, Martin Čaprnda, Ľudovít Gašpar et al. · 2022 · Research Square
94. Additional file 2 of Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression
    Lei Du, Congrong Li, Qifeng He, Xiaohua Li, Linfei Yang, Zou, Yuan, Zhi‐Xia Yang, Dong Zhang, Xiaowei Xing · 2020 · Figshare
95. Additional file 2 of Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
    Meiling Gong, Li, Yan, Xiaoping Ye, Linlin Zhang, Zhifang Wang, Xiaowen Xu, Yejing Shen, Cuixia Zheng · 2020 · Figshare
96. Additional file 1 of Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma
    Tongyan Liu, Han, Chencheng, Panqi Fang, Zhifei Ma, Xiaoxiao Wang, Chen, Hao, Siwei Wang, Fanchen Meng, Cheng Wang, Erbao Zhang et al. · 2022 · Figshare
97. Additional file 1 of Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression
    Du, Lei, Congrong Li, Qifeng He, Xiaohua Li, Linfei Yang, Zou, Yuan, Zhi‐Xia Yang, Dong Zhang, Xiaowei Xing · 2020 · Figshare
98. Additional file 3 of Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression
    Lei Du, Congrong Li, Qifeng He, Xiaohua Li, Linfei Yang, Zou, Yuan, Zhi‐Xia Yang, Dong Zhang, Xiaowei Xing · 2020 · Figshare
99. Investigating the role of HSP90 in cancer cell phenotypic plasticity
    Vincent E. Sollars, Alexandria Chapman, Nicole R. Liang, Seth Myers · 2024 · Journal of Breast Cancer Research
100. Affinity war: PSAT1 outcompetes the rest
     Richard Possemato · 2024 · Nature Metabolism